De Novo device
Hamilton Thorne Zona Infrared Laser Optical System (Zilos Tk)
Hamilton Thorne Biosciences · System, Assisted Reproduction Laser (MRX, Class II) · First FDA decision Nov 4, 2004, newest Nov 4, 2004Infertility
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
1
Naming "Thorne Zona Infrared"
MAUDE reports
0
Brand "Thorne Zona Infrared", since 2015
PubMed studies
0
Mentioning "Thorne Zona Infrared"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Hamilton Thorne Zona Infrared Laser Optical System (Zilos Tk)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- HAMILTON THORNE ZONA INFRARED LASER OPTICAL SYSTEM (ZILOS TK)New device typeDe Novo
DEN040009 · Decided Nov 4, 2004 · 71 days after receipt
Device type: System, Assisted Reproduction Laser (MRX) · Obstetrics & Gynecology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Thorne Zona Infrared", any status and sponsor, newest update first.
- The Effect of Laser-assisted Zona Thinning on the Implantation Rate in the Women of Advanced AgePivotal-lookingStatus unknown
Shanxi Provincial Maternity and Children's HospitalAcademic, hospital or other
NCT01765322 · 150 participants (planned) · Start Nov 2013 · Primary completion Jan 2015
Device: ZILOS-TK IVOS Analyzer · For: Female Urogenital Diseases
Sites: Xi'an, China
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Thorne Zona Infrared", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MRX
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Thorne Zona Infrared"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MRX.
- Assisted Reproduction Laser System (Model ILS-400M)Hua Yue Medical Technology Co., Ltd. · 510(k) 2026
- LYKOS Assisted Reproduction Laser with Dynamic Targeting System (DTS)Hamilton Thorne, Inc. · 510(k) 2021
- LaserShot M, NaviLaseVitrolife GmbH · 510(k) 2020
- Saturn 5 LaserResearch Instruments , Ltd. · 510(k) 2015
- Hanilton Thorne Infrared Laser Optical System-Zilos-Tk Hamilton Thorne Infrared Laser Optical System-LykosHamilton Thorne, Inc. · 510(k) 2012
- Saturn Active Laser SystemResearch Instruments , Ltd. · 510(k) 2009
- Zilos-TkHamilton Thorne Biosciences · 510(k) 2007
- Saturn 3 Laser SystemResearch Instruments , Ltd. · 510(k) 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.